Aurelien Rizk
Co-Founder & CSO at InterAx Biotech | Zurich, Zurich, Switzerland
Aurelien Rizk’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Co-founder at Algorizk in January 2011 - Present
Co-founder & CEO at InterAx Biotech AG in November 2020 - Present
Co-Founder & CSO at InterAx Biotech in January 2023 - Present
Co-founder & CTO at InterAx Biotech AG in April 2016 - November 2020
Post-doc at Paul Scherrer Institut in September 2011 - June 2015
Post-doc at ETH Zurich in September 2011 - August 2012
PhD student at INRIA in January 2007 - December 2011
iGEM team member at CRI in June 2007 - November 2007
Internship at Brandeis University in June 2006 - August 2006
Internship at IMAG Grenoble in May 2005 - June 2005
École normale supérieure de Rennes, August 2026
Paris-Sud University (Paris XI), Master 2, August 2026
InterAx is redefining drug discovery by understanding treatment impact on diseases before pre-clinical trials begin, an analysis traditionally inaccessible to very early programs. Focusing on GPCR small molecules, the Deep Signal™ platform enables superior optimization of drug candidates, leading to differentiated drugs with higher efficacy and safety and lower clinical failure rates. InterAx’s three-asset portfolio demonstrates this impact, including a biologically differentiated GLP-1 asset that addresses the challenges seen with small-molecule competitors, a partnered GIP program, as well as an innovative ACKR3 program driven by unique target understanding. With four additional targets identified, the company is poised to expand into neurologic and autoimmune indications. Growing asset and platform partnerships highlight strong market traction, with future investments set to unlock GLP-1 value and scale the portfolio.
Discover more about InterAx Biotech
CTO at InterAx • Drug Discovery & Life Science • Computational Methods & Technology • Startups
Head of Computational Science + Acting CTO at InterAx Biotech
(Mar 2021 – Present)
Co-Founder, CFO & COO InterAx Biotech
InterAx, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targ...
Chairman of the Board bei InterAx Biotech AG
Eulitha AG develops, manufactures and sells high resolution displacement Talbot lithography (DTL) machines.
Senior Computational Chemist at InterAx Biotech AG
Senior Computational Chemist at InterAx Biotech
(Nov 2022 – Present)
Scientist Discovery & Pharmacology • InterAx Biotech
Scientist Discovery & Pharmacology at InterAx Biotech
(Aug 2025 – Present)
Seasoned Pharmaceutical Executive
Partner at Thaxton Philip Consulting
(Mar 2023 – Present)
What is Aurelien Rizk email address?
Email Aurelien Rizk at [email protected] and [email protected]. This email is the most updated Aurelien Rizk's email found in 2026.
How to contact Aurelien Rizk?
To contact Aurelien Rizk send an email to [email protected] or [email protected]. (updated on July 2026)
What company does Aurelien Rizk work for?
Aurelien Rizk works for InterAx Biotech.
What is Aurelien Rizk's role at InterAx Biotech?
Aurelien Rizk is Co-Founder & CSO
What industry does Aurelien Rizk work in?
Aurelien Rizk works in the Research industry.
